Study S000253

A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Safety and Efficacy of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents (SLIMMER-YOUNG)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07836270
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: TRIPLE
Status: NOT_YET_RECRUITING
Enrollment: 192
Start: 2026-10-31
Primary completion: 2028-06-08
Lead sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Conditions: Adolescents With Obesity; Adolescents With Overweight & Weight-related Comorbidities
Interventions: DRUG:Ecnoglutide Injection; DRUG:placebo with matching volume
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percent change in Body Mass Index (BMI) [Baseline, week 40]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.